Active, Not Recruiting
Nivolumab With Trametinib and Dabrafenib, or Encorafenib and Binimetinib in Treating Patients With BRAF Mutated Metastatic or Unresectable Stage III-IV Melanoma
NCT02910700
- Conditions
- Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +23 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States